Embolization with transient materials
AssigneeIncept, LLC
InventorsAmarpreet S. Sawhney, Timothy S. Jarrett, Hans Claesson
Life of this patent
Estimating the term…
Abstract
Use of embolic material that is biodegradable provides for embolizing a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature or a vessel related to production of ghrelin. The embolic material is biodegradable within a predetermined period of time. Medical systems are configured for delivery of embolic material for embolizing the hypervascular vessel or the vessel related to production of ghrelin.
Claims20
A method of embolizing a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature, the method comprising:
- advancing a catheter through a vasculature to a parent artery;
- and
- releasing an embolic material from a distal end of the catheter into the hypervascular vessel, with the embolic material blocking blood flow in the hypervascular vessel without blocking blood flow to a parent vessel, wherein the embolic material is free of a therapeutic agent and comprises deformable hydrogel particles that are biodegradable within a period of time from 15 minutes to 48 hours.
A medical system for treatment of a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature, the medical system comprising:
- a catheter suitable for delivery through a patient's vasculature to reach the hypervascular vessel;
- and
- a delivery component comprising a reservoir of the embolic material configured for delivery through the catheter, wherein the embolic material is free of a therapeutic agent and comprises deformable hydrogel particles that are biodegradable within a period of time from 15 minutes to 48 hours.
Dependencies are inferred from the claim text.